1-6 of 6
salvage therapy
Close
Sort by
Journal Articles

Where does PD-1 blockade fit in HL therapy?

Alex F. Herrera
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 213–220.
https://doi.org/10.1182/asheducation-2018.1.213
Published: 2018
Journal Articles

Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era

Solomon A. Graf, Ajay K. Gopal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 151–157.
https://doi.org/10.1182/asheducation-2014.1.151
Published: 2014
Journal Articles

Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?

Elizabeth A. Raetz, Teena Bhatla
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 129–136.
https://doi.org/10.1182/asheducation.V2012.1.129.3800156
Published: 2012
Journal Articles

Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?

Christian Gisselbrecht
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 410–416.
https://doi.org/10.1182/asheducation.V2012.1.410.3798518
Published: 2012
Journal Articles

The Treatment of Relapsed and Refractory Multiple Myeloma

Paul Richardson, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Dharminder Chauhan, Nikhil Munshi, Kenneth Anderson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 317–323.
https://doi.org/10.1182/asheducation-2007.1.317
Published: 2007
Journal Articles

Salvage Therapy for CLL and the Role of Stem Cell Transplantation

John G. Gribben
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 292–298.
https://doi.org/10.1182/asheducation-2005.1.292
Published: 2005